HomeGETI-B • STO
add
Getinge AB
Previous close
kr 212.50
Day range
kr 211.70 - kr 214.90
Year range
kr 164.35 - kr 232.30
Market cap
53.83B SEK
Avg Volume
446.15K
P/E ratio
38.72
Dividend yield
2.17%
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 8.24B | -0.81% |
Operating expense | 3.05B | 1.91% |
Net income | 524.00M | 2.14% |
Net profit margin | 6.36 | 2.91% |
Earnings per share | 2.25 | -1.75% |
EBITDA | 1.31B | -0.30% |
Effective tax rate | 26.91% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.94B | -14.92% |
Total assets | 56.37B | 2.06% |
Total liabilities | 27.35B | 16.25% |
Total equity | 29.02B | — |
Shares outstanding | 272.37M | — |
Price to book | 2.01 | — |
Return on assets | 3.84% | — |
Return on capital | 5.44% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 524.00M | 2.14% |
Cash from operations | 841.00M | 38.10% |
Cash from investing | -1.82B | -195.45% |
Cash from financing | -1.47B | -41.52% |
Net change in cash | -2.26B | -110.63% |
Free cash flow | -187.88M | -255.27% |
About
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the Chairman of the Board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Founded
1904
Website
Employees
11,874
